InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Plavsic Mark, Chief Technology Officer. Director active across 1 company, notably Fate Therapeutics INC. Cumulatively, 6 disclosures have been logged. Activity tracked since 14 June 2021. The latest transaction was disclosed on 25 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
33,302 shares0Common StockSEC:0000899243-22-003447
33,302 shares0Common StockSEC:0000899243-22-003447:0
59,540 shares0Common StockSEC:0001209191-21-066162
59,540 shares0Common StockSEC:0001209191-21-066162:0
38,000 shares0Common StockSEC:0001209191-21-042373
38,000 shares0Common StockSEC:0001209191-21-042373:0
6 of 6 declarations
About Plavsic Mark
Mark Plavsic is the Chief Technical Officer at FATE THERAPEUTICS INC. He is responsible for the technical direction and innovation within the company. His expertise in biotechnology is essential for the development of new therapeutic solutions at FATE THERAPEUTICS INC.
